ROBERT CALIFF was appointed commissioner of the FDA, following a successful confirmation vote in the Senate. Califf has served as deputy commissioner for medical products and tobacco since January 2015. Califf was nominated for the post by President Barack Obama in September 2015. Since then, his confirmation has been opposed and blocked by a handful...
A group of melanoma experts, joined by three advocacy groups focused on melanoma, has engaged FDA in a public discussion of the challenges of developing new drugs in the refractory setting and the role crossover can play in such trials.
